Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

4.7K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.7K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

2.9K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.9K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

4.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.2K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

1.9K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.9K
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

13.5K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
13.5K
Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

361
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
361

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Metrics and insulin variations in women with type 1 diabetes on automated insulin delivery system during strict peripartum period.

Acta diabetologica·2026
Same author

Ketogenic and Low-Carbohydrate Diets in Prostate Cancer: Metabolic Rationale, Preclinical Evidence, and Preliminary Clinical Data.

Journal of clinical medicine·2026
Same author

Diabetes and cancer: glucose control impact on survival and tumor outcomes.

Reviews in endocrine & metabolic disorders·2026
Same author

Clinical Impact of Rare Subtypes of Parathyroid Adenoma: A Systematic Review.

Journal of personalized medicine·2026
Same author

Anti-Ma2 Paraneoplastic Encephalitis and Testicular Cancer: When the Hypothalamus Whispers-A Case Report and Systematic Review with Emphasis on Hypothalamic-Endocrine Dysfunction.

Medical sciences (Basel, Switzerland)·2026
Same author

Diabetic Neuropathy and Erectile Dysfunction: Unveiling the Neural Pathways Behind a Vascular Symptom.

Journal of clinical medicine·2026

Related Experiment Video

Updated: Dec 23, 2025

Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model
09:44

Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model

Published on: March 5, 2022

3.2K

Association between type 1 diabetes and female sexual dysfunction.

Virginia Zamponi1,2, Rossella Mazzilli3, Olimpia Bitterman2

  • 1Andrology, Department of Clinical and Molecular Medicine, University of Rome "Sapienza", Sant'Andrea Hospital, via di Grottarossa 1038, University of Rome 'Sapienza', Rome, Italy.

BMC Women'S Health
|April 18, 2020
PubMed
Summary

Female Sexual Dysfunction (FSD) is significantly more common in women with type 1 Diabetes Mellitus (DM) compared to healthy individuals. This highlights the need for increased awareness and screening of FSD in diabetic women.

Keywords:
BMICSIIDiabetes complicationsDiabetes mellitusFSFIFemale sexual dysfunction

More Related Videos

Electrochemiluminescence Assays for Human Islet Autoantibodies
09:15

Electrochemiluminescence Assays for Human Islet Autoantibodies

Published on: March 23, 2018

15.9K
Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid
06:21

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Published on: April 7, 2023

1.9K

Related Experiment Videos

Last Updated: Dec 23, 2025

Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model
09:44

Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model

Published on: March 5, 2022

3.2K
Electrochemiluminescence Assays for Human Islet Autoantibodies
09:15

Electrochemiluminescence Assays for Human Islet Autoantibodies

Published on: March 23, 2018

15.9K
Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid
06:21

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Published on: April 7, 2023

1.9K

Area of Science:

  • Endocrinology
  • Reproductive Health
  • Diabetology

Background:

  • Type 1 Diabetes Mellitus (DM) can impact various aspects of health, including sexual function.
  • Female Sexual Dysfunction (FSD) is a complex condition affecting women's sexual health.
  • Understanding the prevalence and correlates of FSD in type 1 DM is crucial for comprehensive patient care.

Purpose of the Study:

  • To determine the prevalence of Female Sexual Dysfunction (FSD) in women with type 1 Diabetes Mellitus (DM) compared to a control group.
  • To investigate the correlation between DM duration, HbA1C levels, and sexual life quality.
  • To examine the relationship between insulin administration methods, DM complications, and sexual life quality in women with type 1 DM.

Main Methods:

  • A case-control study involving 33 women with type 1 DM and 39 healthy controls.
  • Participants completed a detailed medical history, physical examination, and the 6-item Female Sexual Function Index (FSFI-6) questionnaire.
  • Data on DM duration, HbA1C, insulin administration methods (MDI or CSII), and diabetes complications were collected for the type 1 DM group.

Main Results:

  • The prevalence of FSD was significantly higher in women with type 1 DM (36.4%) compared to controls (5.2%; p=0.010).
  • No significant differences in FSD prevalence were observed based on the presence of diabetes complications, insulin administration method, or previous pregnancies.
  • Correlations between DM duration, HbA1C, and sexual life quality were not detailed in the provided results.

Conclusions:

  • Female Sexual Dysfunction (FSD) is significantly more prevalent in women with type 1 Diabetes Mellitus (DM) than in healthy women.
  • Diabetic neuropathy/angiopathy and potentially insulin administration methods may contribute to FSD in this population.
  • Routine screening for FSD in women with type 1 DM is recommended, similar to screening for erectile dysfunction in men with DM.